Abstract: Snake venom phospholipases A 2 (PLA 2 s) are responsible for numerous pathophysiological effects in snakebites; however, their biochemical properties favour antimicrobial actions against different pathogens, thus constituting a true source of potential microbicidal agents. This study describes the isolation of a Lys49 PLA 2 homologue from Lachesis muta muta venom using two chromatographic steps: size exclusion and reverse phase. The protein showed a molecular mass of 13,889 Da and was devoid of phospholipase activity on an artificial substrate. The primary structure made it possible to identify an unpublished protein from L. m. muta venom, named LmutTX, that presented high identity with other Lys49 PLA 2 s from bothropic venoms. Synthetic peptides designed from LmutTX were evaluated for their cytotoxic and antimicrobial activities. LmutTX was cytotoxic against C2C12 myotubes at concentrations of at least 200 lg/mL, whereas the peptides showed a low cytolytic effect. LmutTX showed antibacterial activity against Gram-positive and Gram-negative bacteria; however, S. aureus ATCC 29213 and MRSA strains were more sensitive to the toxin's action. Synthetic peptides were tested on S. aureus, MRSA and P. aeruginosa ATCC 27853 strains, showing promising results. This study describes for the first time the isolation of a Lys49 PLA 2 from Lachesis snake venom and shows that peptides from specific regions of the sequence may constitute new sources of molecules with biotechnological potential.
In recent years, the search for new antimicrobial agents from natural sources has intensified, such as those from microorganisms [1] , algae [2] , plants [3] , along with anuran [4] , scorpion [5] , spider [6] , wasp [7] , bee [8] and snake venoms [9, 10] that would constitute an important treatment alternative against innumerable emerging or non-emerging infectious diseases that afflict society.
Among these, snake venoms have shown promising antimicrobial activities on different pathogens, such as bacteria, fungi and protozoa [11] [12] [13] . Of the proteins found in these venoms, phospholipases A 2 (PLA 2 s) represent one of the main classes of molecules responsible for such activities [12, [14] [15] [16] .
A subgroup of PLA 2 s within this family can induce tissue damage by mechanisms independent of catalysis. These proteins, called PLA 2 homologues or Lys49 PLA 2 s, present a substitution of the aspartate residue at position 49 for a lysine residue, which prevents the co-ordination of Ca 2+ ions in the binding loop, leading to loss of enzymatic activity [17] . Although they do not hydrolyse membrane phospholipids, PLA 2 homologues can cause local myonecrosis and oedema [18, 19] and exert antimicrobial action on a variety of pathogenic microorganisms [11, 20] . Recent studies suggest that residues located in the C-terminal region of the molecule (consisting of a combination of hydrophobic and cationic residues) may be involved in the destabilization and perturbation of biological membranes, with a preference for anionic phospholipids [21, 22] . C-terminal peptides derived from PLA 2 homologues have been evaluated for their microbicidal and antitumour potential [20, 23, 24] , presenting promising results.
The snake Lachesis muta muta, also known as 'surucucu pico-de-jaca' or 'bushmaster', is the largest venomous snake in the Americas. Because it inhabits remote forest areas, this snake is difficult to find and/or keep in captivity, with few published studies due to the difficulty in obtaining its venom [25] [26] [27] .
This study describes, for the first time, the isolation and biochemical characterization of a PLA 2 Lachesis muta muta snake venom, called LmutTX, and demonstrates that synthetic peptides derived from the primary structure of the protein may represent possible antibacterial agents against multiresistant bacteria.
Material and Methods
Venom. The lyophilized venom of the snake Lachesis muta muta (LmmV) was obtained from the serpentarium BioAgents (Batatais-SP, Brazil). The study was authorized by the Brazilian Institute of Environment and Renewable Natural Resources (licence number 27131-1).
Synthetic peptides. The peptides synthesized from residues 1-12 (SLVELGKMILQE -PepN and PepN-W), 41-52 (DRCCYVHKC CYK -PepS and PepS-W) and 105-116 (KKYNYLKPFCKK -PepC and PepC-W) were obtained from Aminotech Research and Development, Diadema -SP, Brazil, with a degree of purity greater than 97%. The modified peptides (represented by letter W) correspond to the original sequence with the substitution of valine residue (PepN-W) and tyrosine residue (PepS-W and PepC-W) by tryptophan.
Isolation of the LmmV toxin. LmmV was solubilized in a 0.5 M ammonium bicarbonate buffer pH 8.0 and applied to a Sephacryl S200 chromatography column (10 9 30 cm; GE Lifescience Health Care, Uppsala, Sweden), coupled with an Akta Purifier HPLC system (GE Lifescience Health Care). The fraction of interest was submitted to fractionation in a C18 reverse-phase column (25 9 4.6 mm, 5 lm -Discovery Supelco) using 0.1% trifluoroacetic acid (TFA -Sigma Aldrich, Missouri, USA; Eluent A) and 99.9% acetonitrile (ACNSigma Aldrich, USA) + 0.1% TFA (Eluent B) as solutions, at a flow rate of 1 mL/min and linear gradient of 0-70%. The absorbance was measured at 280 nm.
Measurement of protein concentration. The quantification of LmmV proteins, fractions and toxin followed the modified Lowry method (DC Protein, Bio-Rad, California, USA), using bovine serum albumin (BSA) as a standard.
One-dimensional electrophoresis. The procedure for one-dimensional electrophoresis was performed according to Laemmli [28] . Determination of the relative mass of the proteins was evaluated by SDS-PAGE using gels in discontinuous formats with a concentrator gel (4% acrylamide in 0.5 M Tris-HCl buffer, pH 6.8; Sigma Aldrich) and a separating gel (12.5% acrylamide in 1.5 M Tris-HCl buffer, pH 8.8). The experimental buffer solution used to fill the well reservoirs was formed by 0.06 M Tris-base, 0.5 M glycine and 10% SDS (Sigma Aldrich). The samples were preheated at 95°C for 5 min. and applied to the concentrator gel wells along with the molecular mass standard (7 to 175 kDa; BioLabs P7709S, Massachusetts, USA, or 9 to 200 kDa; Amresco's BlueStep K973, Texas, USA). In the electrophoretic experiment, a current of 15 mA per gel and free voltage was fixed for 1 hr and 40 min.
After the experiment, the gel was washed for 15 min. with a fixing solution (50% ethyl alcohol and 12% acetic acid) and then stained with Coomassie G-250 blue solution (Sigma Aldrich) for 10-30 min. After this period, the gel was destained in bleach solution (20% ethyl alcohol and 3% acetic acid). Images of the gels were scanned in an ImageScanner III (GE Lifescience Health Care).
Phospholipase activity on 4N3OBA. The procedure was performed as described by Petrovic et al. [29] with modifications. The substrate 4-nitro-3-octanoyloxy-benzoic acid (4N3OBA; Enzo Lifescience, New York, USA; 5 mg) was diluted in 5.4 mL of acetonitrile; 0.2 mL aliquots was dried and maintained at À20°C. Each tube containing 4N3OBA was diluted in 2 mL of sample buffer (0.01 M Tris-HCl at pH 8.0, 0.01 M CaCl 2 and 0.1 M NaCl; Sigma Aldrich) and kept on ice. To determine the phospholipase activity, 190 lL of 4N3OBA reagent was combined with 10 lL of sample [crude venom and/or fractions, BthTX-2 (positive control) or water (negative control)] and immediately incubated at 37°C; the absorbance was measured at 425 nm for 30 min. Phospholipase activity was considered to be directly proportional to the increase in absorbance values, expressed as mean AE standard deviation and submitted to analysis of variance (ANOVA) followed by the Tukey post-test for p < 0.05.
Sequencing and molecular modelling of LmutTX. The isolated toxin was sequenced using two techniques: (i) N-terminal sequencing by Edman degradation, in which the sequence was determined by a PPSQ-33A automatic sequencer (Shimadzu, Kyoto, Japan), and subsequently subjected to a similarity search using BLAST software, with successive multiple alignment through CLUSTALW2; and (ii) mass spectrometry in which the protein was digested with trypsin (Sequencing grade-modified trypsin; Promega, Wisconsin, USA), according to the manufacturer's instructions (protease:protein ratio of 1:20 w/w), and the fragments obtained from the digestion were analysed in an ESI-IT-TOF (electrospray-ion trap-time of flight) spectrometer (Shimadzu Co., Kyoto, Japan) equipped with UFLC (ultra-fast liquid chromatography; 20A Prominence; Shimadzu). The generated MS/MS spectra were analysed using the software Peaks Mass Spectrometry (Bioinformatics Solutions Inc., Waterloo, Canada), and the accuracy was calculated according to Coutinho-Neto et al. [30] .
To investigate structural characteristics of the amino acids, we performed homology modelling of LmutTX's sequence using the crystal structure of MTX-II from Bothrops brazili (PDB code: 4DCF) as template, with a resolution of 2.7 A [31] and the structure of an acidic PLA 2 from Deinagkistrodon acutus (PDB code: 1IJL) [32] . To search and retrieve the template structure, Protein Blast (http://blast.ncbi.nlm. nih.gov) [33] and Protein Data Bank (PDB; http://www.pdb.org) were used. The sequence alignments were carried out in MODELLER v9.16 [34] and ClustalW [35] software. Model building was carried out in MODELLER v9. 16 . A total of 1000 models were generated, and the final model was selected based on the lowest DOPE scores calculated by the MODELLER software. The overall stereochemical quality of the final model for LmutTX was assessed using the program PROCHECK [36] . Interactive visualization and comparative analysis of molecular structures were carried out in UCSF Chimera [37] .
Antimicrobial activity. The antibacterial activity was established according to the Clinical and Laboratory Standards Institute [38] . The percentage of inhibition of bacterial growth was determined using a microdilution susceptibility test; the bacteria used were Staphylococcus aureus (ATCC 29213), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (ATCC 27853), Klebsiella pneumoniae (ATCC 13883) and Escherichia coli (ATCC 25922). All bacterial strains were cultured in Luria Bertani broth (LB -BD Difco TM , New Jersey, USA) for 24 hr (exponential phase) and adjusted to a turbidity absorbance corresponding to 0.5 on the McFarland scale, signifying 1.5 9 10 6 colony-forming units/mL. The samples were incubated with the bacteria at concentrations of 12.5 lg/mL for LmutTX and 125, 62.5, 31.2, 15.6 and 7.8 lg/mL for the synthetic peptides with a final volume of 200 lL and analysed in 96-well microplates for 24 and 48 hr at 37°C. The bacterial suspension in LB broth and the antibiotics imipenem (LmutTX) and chloramphenicol (peptides, 20 lg/mL; Sigma Aldrich) were used as controls. LB broth alone was used as a negative control. Inhibition of bacterial growth was determined by spectrophotometry at a wavelength of 630 nm (TC 96 ELISA Microplate Reader). The results were expressed as mean AE standard deviation and submitted to analysis of variance (ANOVA) followed by the Tukey post-test with a significance level of p < 0.05. The experiments were performed in triplicate (n = 3).
Cytotoxicity on differentiated C2C12 muscle cells in myotubes. The procedure was performed according to Lomonte et al. [39] with modifications. C2C12 cells (murine myoblast cell line ATCC â CRL-1772 TM , Virginia, USA) were grown in DMEM (Dulbecco's modified Eagle's medium; Sigma Aldrich) supplemented with 10% foetal bovine serum (FBS; Sigma Aldrich), 2 g/L HEPES, 3.7 g/L bicarbonate and 50 lg/mL of gentamicin (Sigma Aldrich) in a humidified atmosphere with 5% CO 2 at 37°C. An initial suspension of 2 9 10 4 cells was plated in 96-well plates and incubated for 4 days. After this period, the growth medium was replaced by DMEM with 1% FBS, for 4-6 days. For the cytotoxicity assay, the protein and peptides were diluted in PBS and added to the cell culture, in a total volume of 200 lL/well. Controls of 0% and 100% toxicity consisted of cell medium and Triton X-100 (Sigma Aldrich), respectively. After 3 hr of incubation, 150 lL aliquots of the supernatant was collected to determine the activity of lactic dehydrogenase (LDH), released due to cell damage, using a commercial kit (LDH Ref. K014, Bioclin, Brazil). The results were expressed as mean AE standard deviation and submitted to analysis of variance (ANOVA) followed by the Tukey post-test with a significance level of p < 0.05. The experiments were performed in triplicate (n = 3).
Results
Purification and physical-chemical characterization of a PLA 2 homologue from Lachesis muta muta venom (LmmV). LmmV was fractionated in two chromatographic steps: size exclusion and reverse phase. In the first step, four fractions, with snake venom PLA 2 s) and when submitted to an evaluation of the phospholipase activity on an artificial substrate, neither presented significant activity ( fig. 1B) . Due to the low amount of protein in the LmS-4 fraction, the study was directed to the LmS-3 fraction (which corresponds to approximately 2% of the protein content of the venom). In the second step, the LmS-3 fraction was chromatographed on a reverse-phase column, where six fractions (P1 to P6) were eluted; 12.5% SDS-PAGE of the fractions in reducing conditions showed that the fraction P6 consisted of a single protein band (<19 kDa), whereas the other fractions showed no visible bands ( fig. 2A) , possibly because they contain peptide fractions. Evaluation of the phospholipase activity of the P6 fraction showed that it was devoid of enzymatic activity, as there was no statistically significant difference between the negative control and P6 ( fig. 2B ), possibly being a PLA 2 homologue. The sample was subjected to a second step of chromatographic fragmentation in a reversephase column to ascertain its purity, which was confirmed by the elution of a single fraction ( fig. 2C ) in 36% Eluent B and the presence of a single protein band on 15% SDS-PAGE. The precise determination of the molecular mass of P6 was performed by mass spectrometry, where the protein presented an m/z value of 13,890 and only one peak in the mass spectrum ( fig 2D) . The purified protein corresponded to 0.8% of the venom protein content and was named LmutTX.
Sequencing and molecular modelling of LmutTX. The primary structure of LmutTX was determined using two techniques: (i) Edman degradation sequencing, obtaining the first 57 amino acid residues from the N-terminal region of the molecule, and (ii) mass spectrometry by analysing the peptides' fragmentation spectra generated from enzymatic digestion, with the elucidation of 63 amino acid residues. A total of 120 residues were determined, completing 98.36% of the sequence, with only two residues located in the non-sequenced C-terminal region. The fragments obtained from enzymatic digestion, with their respective regions in the primary structure and molecular masses, are listed in table 1. fig. 3 ). This is the first description of a snake venom Lys49 PLA 2 from the genus Lachesis. The amino acid sequence of LmutTX showed conserved residues within Lys49 PLA 2 s, such as His48, Asp99, Tyr52 and Tyr73 (active site) and the Tyr28?Asn, Gly32?Leu and Asp49?Lys substitutions
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Ca 2+ -binding loop Helix α3 (Ca 2+ binding loop), according to the numbering system proposed by Renetseder et al. [40] . The template 4DCF showed 95% similarity to the LmutTX sequence. Despite the high similarity, the modelling is important for the verification of the amino acid positions of the active site. The analysis of the Ramachandran plot [41] showed that more than 90.4% of the amino acids of the LmutTX were in favourable regions and RMSD between structures resulted in 0.52 A. Thus, the models are reasonably good and quite similar to the template (fig. 3B ).
C-terminal
LmutTX's structural model presented all conserved secondary structures for group IIA PLA 2 s, such as the N-terminal helix (a1), the two long antiparallel helices (a2 and a3), one short helix, the two antiparallel b-sheets (b-wing) and the Cterminal region.
As many studies with Lys49 PLA 2 s [20, 23, 24, 42] have suggested the involvement of specific protein regions in the perturbation of biological membranes, six peptides were designed and synthesized, three identical to the sequence (PepC -Cterminal region; PepN -N-terminal region; PepS -region containing the catalytic site) along with three peptides that were modified from the original peptide sequence (PepC-W, PepN-W and PepS-W), by replacing tyrosine residues by tryptophan residues (Tyr ? Trp), to increase the degree of hydrophobicity of the designed peptides ( fig. 3B ).
Functional characterization of LmutTX.
Cytotoxicity of LmmV, LmutTX and synthetic peptides against differentiated C2C12 cells in myotubes. To evaluate the cytotoxic effect of LmmV, LmutTX and synthetic peptides, a line of murine myoblasts (C2C12) was used in different sample concentrations. LmmV was cytotoxic at all concentrations tested (25-300 lg/mL), showing maximal action at concentrations above 50 lg/mL, whereas LmutTX was only cytotoxic above 200 lg/mL (fig. 4A ). The peptides showed low cytotoxicity on the cells, reaching approximately 30% of maximum cell damage at 600 lg/mL with the peptide PepC-W (fig. 4B) . The other peptides presented cell damage below 20% at all concentrations tested.
Antimicrobial activity of LmutTX and synthetic peptides against different Gram-positive and Gram-negative bacteria. To observe LmutTX's antibacterial action, it was tested against Gram-positive (S. aureus and MRSA) and Gram-negative strains (E. coli, P. aeruginosa and K. pneumoniae) at a concentration of 12.5 lg/mL over 24 and 48 hr. The protein was able to inhibit 60% of growth of S. aureus and MRSA strains for 24-and 48-hr periods. An inhibition of~35% was observed for P. aeruginosa in 24 hr, increasing this percentage to 50% in 48 hr;~30% of K. pneumoniae growth was inhibited by the toxin in both incubation periods (fig. 5 ). E. coli bacteria were not susceptible to the toxin's action at the concentration evaluated. As S. aureus, MRSA and P. aeruginosa were most susceptible to LmutTX, they were selected for antimicrobial activity tests with synthetic peptides.
Of the six synthesized peptides, only those corresponding to the C-terminal region (PepC and PepC-W) showed significant activity against the selected bacteria. PepC inhibited 60% of MRSA growth at concentrations of 125 and 62.5 lg/mL in 24 hr ( fig. 6A ), while PepC-W inhibited 100-95% of MRSA growth at concentrations of 125 to 7.8 lg/mL over a period of 24 hr, maintaining this activity for 48 hr (fig. 6B ). The same action was observed for PepC-W against P. aeruginosa, where the peptide was able to inhibit 100% of bacterial growth at a concentration of 125 lg/mL and~90% at 62.5 lg/mL after 24 hr, retaining approximately 80% inhibition for 48 hr (fig. 6D ). PepC had no significant activity on P. aeruginosa ( fig. 6C ).
Discussion
Among the sources of biodiversity, snake venoms are proving to be conducive to the discovery of compounds or biological activities with therapeutic potential due to their variety of proteins, enzymes and peptides [43, 44] . Few proteins have been isolated from Lachesis muta muta venom [45] [46] [47] [48] [49] , which allows for the identification of many unknown molecules that are common to other genera. This study describes the isolation and characterization of the first Lys49 PLA 2 for L. m. muta venom, called LmutTX. Purification of the protein followed methodologies commonly used to obtain Asp49 PLA 2 s from laquetic venoms, such as LmTX-I, LmTX-II, LM-PLA 2 -I and LM-PLA 2 -II [50, 51] . Variability in the expression of PLA 2 s in snake venoms of the genus Lachesis, as reported by Sanz et al. [25] , may have been one of the factors that hindered the prior purification of Lys49 PLA 2 s from these venoms, as well as their identification using transcriptomic studies, as mentioned by Junqueira-de-Azevedo et al. [52] . LmutTX presented a molecular mass of 13,889 Da and was devoid of phospholipase activity on an artificial substrate. Its primary structure had high identity with other PLA 2 homologues from bothropic venoms [11, 53] , only differing at five residues (Val19, Thr20, Ser34, Tyr119 and Tyr121), as well as at two non-sequenced residues (positions 117 and 118). The residues that form the catalytic site of Asp49 PLA 2 s (His48, Asp99, Tyr52 and Tyr73) are conserved in Lys49 PLA 2 s, along with the natural mutations at the residues Tyr28 ? Asn, Gly32 ? Leu and Asp49 ? Lys, which make it impossible to co-ordinate Ca 2+ in the ion-binding site [53, 54] .
Lys49 PLA 2 s induce myonecrosis by mechanisms independent of phospholipid hydrolysis [55] . Several mechanisms have been proposed to explain its toxic action on cell membranes [53, 56, 57] ; however, understanding the structure-function relationship of these peculiar toxins is not a simple task. Fernandes et al. [53] suggested a mechanism of action based on the C-terminal region of these myotoxins, where the presence of hydrophobic and cationic residues in this segment The peptides were diluted at concentrations of 125, 62.5, 31.2, 15.6 and 7.8 lg/mL and incubated with S. aureus ATCC 29213, MRSA and P. aeruginosa ATCC 27853 over 24-and 48-hr periods. Chloramphenicol was used as a positive control. The assay was performed in triplicate from three individual experiments, and the results were expressed as mean AE standard deviation, followed by analysis of variance using ANOVA and Tukey post-test for p < 0.05 (*) in relation to the growth control.
would aid in the interaction with and perturbation of biological membranes, which would induce the release of ions and molecules, intensifying tissue damage. Disruption of the bilayer can trigger, as a consequence, the influx of Ca 2+ and the release of K + and ATP to the extracellular medium [58, 59] , involving the participation of purinergic receptors [60] . Kini et al. [61] reported that the variation in the toxic effects of PLA 2 s is based on the differences in protein membrane penetrability. This variation may be closely linked to key changes in the primary structure located in regions that are crucial for the action of these proteins. LmutTX showed a low cytotoxic effect on differentiated C2C12 cells in myotubes compared to other myotoxins from bothropic venoms [39] , as 100 lg/mL was not able to induce LDH release significantly, being only observed at concentrations above 200 lg/mL. Differences were also found in MT-II (Lys49) from B. asper and LmTX-I (Asp49) from L. m. muta, where MT-II was cytotoxic at concentrations ≥30 lg/mL, while LmTX-I did not affect cell viability at any of the tested concentrations (70 to 270 lg/mL) [62, 63] . The cytolytic action of Lys49 PLA 2 s is not restricted to muscle cells but also to other cell types, such as endothelial cells [64] , macrophages [60] , lymphocytes [65] and tumour cell lines [66, 67] .
Amphipathic substances are characterized by their cytotoxic activity on eukaryotic and prokaryotic cells [68] . Based on this principle, the peptide PepC-W, modified with the insertion of hydrophobic residues (substitution of Tyr ? Trp and Tyr ? Phe) and containing a positive net charge of +5, presented a discrete increase in the cytotoxic effect on C2C12 myotubes, as observed by Lomonte et al. [68] . The peptide PepC-W exhibited a different spatial distribution of hydrophobic residues from that of the peptide p115-W3 as described by these authors, as well as fewer residual positive charges, which may have led to different cytotoxic conformations and potential. Regarding the spatial positioning of amino acid residues, Lomonte, Angulo and Santamar ıa [69] showed that some of the peptides in positions 115-129 may have their toxic activities abolished when their amino acid sequences are randomly positioned, suggesting the importance of preserving certain domains in the molecule to maintain its activity.
C-terminal peptides derived from Lys49 PLA 2 s also present cytotoxicity on tumour cell lines originating from lymphoid leukaemia (Jurkat), adenocarcinoma (SKBR3), melanoma (B16F10), sarcoma (S180) [67] , myeloma (P3X) and breast cancer (EMT6) [70] , in addition to extensive activity on bacterial cells [20, 71, 72] .
The antibacterial evaluation of LmutTX and synthetic peptides showed promising activity. LmutTX presented action against Gram-negative and Gram-positive bacteria. The antibacterial action of PLA 2 homologues has been well described, such as BnuTX-I (B. n. urutu) with activity on P. aeruginosa [73] ; MTX-II (B. brazili) on E. coli [23] ; CoaTX-II (C. o. abyssus) on P. aeruginosa, E. coli and S. aureus [14] ; and MjTX-II on E. coli [11] . Among the synthetic peptides from LmutTX that were tested, PepC-W completely inhibited bacterial growth of P. aeruginosa and MRSA strains. The peptide PepC also had action on MRSA, though less than that of the modified peptide. This difference in activity may be associated with the level of hydrophobicity between the two C-terminal peptides (PepC ? 25% and PepC-W ? 41.67%) or even with favourable conformational changes originating from the modification of Tyr/Phe ? Trp residues in PepC-W, as the number of positive charges is evenly arranged between them.
Peptides derived from the C-terminal region of PLA 2 homologues have been the focus of many studies to elucidate their contribution in the mechanism of myotoxic action of these proteins and/or in their use as possible antimicrobial [20, 23] and antitumour agents [66, 67, 70, 74] . P aramo et al. [20] showed that a C-terminal peptide, named p115-129 from B. asper's myotoxin II, had potent activity on strains of E. coli and S. aureus, via interaction with LPS and lipoteichoic acid molecules, respectively, with irreversible morphological changes in the membrane and cell death. Santamar ıa et al. [72] also demonstrated the interaction of C-terminal peptides with LPS molecules, suggesting possible mechanisms of action for cationic peptides.
Among the peptides evaluated in the present study, PepC-W showed activity against Gram-positive (MRSA) and Gramnegative bacteria (P. aeruginosa), although it was more selective for Gram-positive bacteria, as it not only completely inhibited their growth at low concentrations but also maintained its action for 48 hr.
The mechanism of action of this peptide is unknown, but its cationic and hydrophobic characteristics may favour electrostatic interactions between components of the outer membrane and the cell wall of Gram-positive bacteria, similar to teichoic acids, and assist in the insertion of hydrophobic residues in the bilayer. On the other hand, a more specific action cannot be ruled out as S. aureus and MRSA must share extracellular components, such as lipids, carbohydrates, peripheral or transmembrane proteins, glycoconjugates, among others, [75] with physicochemical or structural properties propitious to PepC-W activity; however, S. aureus strains were less sensitive to the peptide (data not shown), suggesting that other factors (or molecular targets) may be involved in the activity against MRSA.
The therapeutic application of peptides is still a challenge to be overcome due to the numerous difficulties in oral administration of peptide drugs, which include the acidic and enzymatic degradation of these molecules in the gastrointestinal tract, as well as their passage through intestinal mucosal cells via active transport or passive diffusion [76] . However, several chemical strategies have been used to stabilize the secondary structures of drug-candidate peptides, such as cyclization, Nmethylation, addition of staples and construction of hydrophobic surfaces [76, 77] .
Even though it is in preliminary in vitro tests, the antibacterial potential of PepC-W is notorious. Its efficiency in inhibiting the growth of resistant bacteria to conventional drugs makes it a promising candidate in the fight against pathogenic microorganisms.
The characterization of LmutTX, the first Lys49 PLA 2 to be described from venoms of the genus Lachesis, and its synthetic peptides, with antibacterial activity on resistant strains and low cytotoxicity in murine C2C12 cells, shows the relevance of the present study and reveals new possibilities for the application of peptides derived from proteins as potential antimicrobial agents.
